Jian-Yue Jin1, Anxin Gu2, Weili Wang3, Nancy L Oleinick3, Mitchell Machtay4, Feng-Ming Spring Kong5. 1. Department of Radiation Oncology, University Hospitals, Cleveland Medical Center, United States; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, United States. Electronic address: jian-yue.jin@UHhospitals.org. 2. Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, United States; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, China. 3. Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, United States. 4. Department of Radiation Oncology, University Hospitals, Cleveland Medical Center, United States; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, United States. 5. Department of Radiation Oncology, University Hospitals, Cleveland Medical Center, United States; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, United States; Departments of Clinical Oncology, Hong Kong University Shenzhen Hospital, and Hong Kong University, Hong Kong, China.
Abstract
PURPOSE: "FLASH" radiotherapy (RT) is a potential paradigm-changing RT technology with marked tumor killing and normal tissue sparing. However, the mechanism of the FLASH effect is not well understood. We hypothesize that the ultra-high dose rate FLASH-RT significantly reduces the killing of circulating immune cells which may partially contribute to the reported FLASH effect. METHODS: This computation study directly models the effect of radiation dose rate on the killing of circulating immune cells. The model considers an irradiated volume that takes up A% of cardiac output and contains B% of total blood. The irradiated blood volume and dose were calculated for various A%, B%, blood circulation time, and irradiation time (which depends on the dose rate). The linear-quadratic model was used to calculate the extent of killing of circulating immune cells at ultra-high vs. conventional dose rates. RESULTS: A strong sparing effect on circulating blood cells by FLASH-RT was noticed; i.e., killing of circulating immune cells reduced from 90% to 100% at conventional dose rates to 5-10% at ultra-high dose rates. The threshold FLASH dose rate was determined to be ~40 Gy/s for mice in an average situation (A% = 50%), consistent with the reported FLASH dose rate in animal studies, and it was approximately one order of magnitude lower for humans than for mice. The magnitude of this sparing effect increased with the dose/fraction, reached a plateau at 30-50 Gy/fraction, and almost completely vanished at 2 Gy/fraction. CONCLUSION: We have calculated a strong sparing effect on circulating immune cells by FLASH-RT, which may contribute to the reported FLASH effects in animal studies.
PURPOSE: "FLASH" radiotherapy (RT) is a potential paradigm-changing RT technology with marked tumor killing and normal tissue sparing. However, the mechanism of the FLASH effect is not well understood. We hypothesize that the ultra-high dose rate FLASH-RT significantly reduces the killing of circulating immune cells which may partially contribute to the reported FLASH effect. METHODS: This computation study directly models the effect of radiation dose rate on the killing of circulating immune cells. The model considers an irradiated volume that takes up A% of cardiac output and contains B% of total blood. The irradiated blood volume and dose were calculated for various A%, B%, blood circulation time, and irradiation time (which depends on the dose rate). The linear-quadratic model was used to calculate the extent of killing of circulating immune cells at ultra-high vs. conventional dose rates. RESULTS:A strong sparing effect on circulating blood cells by FLASH-RT was noticed; i.e., killing of circulating immune cells reduced from 90% to 100% at conventional dose rates to 5-10% at ultra-high dose rates. The threshold FLASH dose rate was determined to be ~40 Gy/s for mice in an average situation (A% = 50%), consistent with the reported FLASH dose rate in animal studies, and it was approximately one order of magnitude lower for humans than for mice. The magnitude of this sparing effect increased with the dose/fraction, reached a plateau at 30-50 Gy/fraction, and almost completely vanished at 2 Gy/fraction. CONCLUSION: We have calculated a strong sparing effect on circulating immune cells by FLASH-RT, which may contribute to the reported FLASH effects in animal studies.
Authors: Matthew H Stenmark; Xu-Wei Cai; Kerby Shedden; James A Hayman; Shuanghu Yuan; Timothy Ritter; Randall K Ten Haken; Theodore S Lawrence; Feng-Ming Spring Kong Journal: Int J Radiat Oncol Biol Phys Date: 2012-10-01 Impact factor: 7.038
Authors: Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takashi Yokoi; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Catherine Wadsworth; Giovanni Melillo; Haiyi Jiang; Yifan Huang; Phillip A Dennis; Mustafa Özgüroğlu Journal: N Engl J Med Date: 2017-09-08 Impact factor: 91.245
Authors: Susannah Yovino; Lawrence Kleinberg; Stuart A Grossman; Manisha Narayanan; Eric Ford Journal: Cancer Invest Date: 2013-02 Impact factor: 2.176
Authors: Michele M Kim; Arash Darafsheh; Jan Schuemann; Ivana Dokic; Olle Lundh; Tianyu Zhao; José Ramos-Méndez; Lei Dong; Kristoffer Petersson Journal: IEEE Trans Radiat Plasma Med Sci Date: 2021-06-22
Authors: Jungwook Shin; Shu Xing; Lucas McCullum; Abdelkhalek Hammi; Jennifer Pursley; Camilo A Correa; Julia Withrow; Sean Domal; Wesley Bolch; Harald Paganetti; Clemens Grassberger Journal: Phys Med Biol Date: 2021-08-03 Impact factor: 4.174
Authors: Shouyi Wei; Haibo Lin; J Isabelle Choi; Robert H Press; Stanislav Lazarev; Rafi Kabarriti; Carla Hajj; Shaakir Hasan; Arpit M Chhabra; Charles B Simone; Minglei Kang Journal: Front Oncol Date: 2022-01-13 Impact factor: 6.244
Authors: Jian-Yue Jin; Chen Hu; Ying Xiao; Hong Zhang; Rebecca Paulus; Susannah G Ellsworth; Steven E Schild; Jeffrey A Bogart; Michael Chris Dobelbower; Vivek S Kavadi; Samir Narayan; Puneeth Iyengar; Cliff Robinson; Joel S Greenberger; Christopher Koprowski; Mitchell Machtay; Walter Curran; Hak Choy; Jeffrey D Bradley; Feng-Ming Spring Kong Journal: Cancers (Basel) Date: 2021-12-08 Impact factor: 6.639